Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53 encodes the tumor suppressor protein p53, a transcription factor that regulates cell division and prevents uncontrolled cell proliferation. It plays a central role in maintaining genomic stability by responding to cellular stresses, inducing cell cycle arrest, apoptosis, senescence, or DNA repair. Mutations in TP53 are the most common genetic alterations in human cancers, leading to loss-of-function or gain-of-function effects that promote tumor development.
Restoration of p53 function is a therapeutic goal; current strategies focus on immunotherapeutic approaches targeting mutant p53 peptides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumour suppressor protein p53 (TP53).